Phase I-II study of irinotecan plus nedaplatin with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1574231875729954688
  • NII Article ID
    10026446869
  • Data Source
    • CiNii Articles

Report a problem

Back to top